EUVIMEDEUVIMED entdecken
Crossref

9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease

Sudesna Das, Prasad Sunnapu, Mohammed Rafi, Yasmin Begum, Sudip Dey, Akshay Joshi, Nittu Singh, Krishan Gopal Thakur, Parasuraman Jaisankar, Umesh Prasad Singh

Molecular Diversity · 2025

DOI: 10.1007/s11030-025-11315-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Sudesna Das und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Hauptthemen laut MEDLINE: Sulfonamides, SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, CSIR - Indian Institute of Chemical Biology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tilorone, a 9-fluorenone scaffold-based molecule, is a known broad-spectrum antiviral with an IC50 of 180 nM against SARS-CoV-2, but its mechanism is not known. In the present study, we found it to have weak activity against PLpro (IC50 = 30.7 ± 7.5 μM) and was inactive against Mpro. Several sulfonamide derivatives of 9-fluorenone, having the same scaffold as tilorone, were synthesized based on our in-silico studies to enhance their protease activity. They were evaluated for their inhibitory potential for targeting SARS-CoV-2 Mpro (main protease) and PLpro (papain-like protease) using FRET-based high-throughput screening and gel-based assays. Among the derivatives, 3e exhibited dual inhibition against Mpro (IC50 = 23 ± 3.4 μM) and PLpro (IC50 = 6.33 ± 0.5 μM), while 3h selectively inhibited PLpro (IC50= 5.94 ± 1.0 μM). Both 3e and 3h suppressed SARS-CoV-2 replication with IC50 values of 13.4 ± 0.28 μM and 18.2 ± 3.2 μM, respectively. Molecular docking and dynamics studies revealed that the NO2 group in 3h enhances the rigidity of the BL2 loop of PLpro, contributing to its higher PLpro activity. Both 3e and 3h showed antiviral activity comparable with standard alpha-ketoamide inhibitor (13b-K) in cell-based assays and were non-cytotoxic with acceptable selectivity indices (S.I. > 5.5). These findings suggest that 9-fluorenone-based sulfonamides, particularly 3e and 3h, may be promising candidates as dual or selective protease inhibitors against SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesSARS-CoV-2Coronavirus 3C ProteasesAntiviral AgentsProtease InhibitorsCoronavirus Papain-Like ProteasesFluorenesMolecular Docking SimulationHumansCOVID-19 Drug TreatmentCOVID-19

Stichwörter der Autor:innen

In-silico structure9-fluorenone scaffoldBased dockingDual-protease inhibitorFRET-based assayHigh-throughput screeningMain protease (Mpro)Molecular dynamics (MD) simulationPapain-like protease (PLpro)SARS-CoV-2Sulfonamide derivativesTilorone

Substanzen

SulfonamidesCoronavirus 3C ProteasesAntiviral AgentsProtease InhibitorsCoronavirus Papain-Like ProteasesFluorenespapain-like protease, SARS-CoV-2

Autor:innen und Institutionen

  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Infectious Diseases and Immunology Division, Council of Scientific and Industrial Research- Indian Institute of Chemical Biology (CSIR-IICB), Jadavpur, Kolkata, 700032, India.
  • Organic and Medicinal Chemistry Division, Laboratory of Catalysis and Chemical Biology, Council of Scientific and Industrial Research- Indian Institute of Chemical Biology (CSIR-IICB), Jadavpur, Kolkata, 700032, India.
  • Council of Scientific and Industrial Research- Institute of Microbial Technology (CSIR-IMTECH), Chandigarh, 160036, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. umesh.singh@iicb.res.in.
  • Infectious Diseases and Immunology Division, Council of Scientific and Industrial Research- Indian Institute of Chemical Biology (CSIR-IICB), Jadavpur, Kolkata, 700032, India. umesh.singh@iicb.res.in.

Förderung

  • Council of Scientific and Industrial Research, India
  • CSIR - Indian Institute of Chemical Biology

Zitieren

APA

Das, S., Sunnapu, P., Rafi, M., Begum, Y., Dey, S., Joshi, A., Singh, N., Thakur, K. G., Jaisankar, P., & Singh, U. P. (2025). 9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease. Molecular Diversity. https://doi.org/10.1007/s11030-025-11315-2

Vancouver

Das S, Sunnapu P, Rafi M, Begum Y, Dey S, Joshi A, et al. 9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease. Molecular Diversity. 2025. doi:10.1007/s11030-025-11315-2

BibTeX
@article{Das2025,
  author = {Das, Sudesna and Sunnapu, Prasad and Rafi, Mohammed and Begum, Yasmin and Dey, Sudip and Joshi, Akshay and Singh, Nittu and Thakur, Krishan Gopal and Jaisankar, Parasuraman and Singh, Umesh Prasad},
  title = {9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-025-11315-2}
}
Kostenlos starten →